Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Novo Nordisk Stock Drops on New Obesity Drug Findings. Eli Lilly Stands to Gain.
In This Article:
The Danish company said the average weight loss was 15.7% for the new drug, CagriSema. The expectation had been about 25%.
Terms and Privacy Policy